Bruce Bauer is the founder of TAE Life Sciences. TAE Life Sciences has raised $40M in total funding. Latest round: Series A. Backed by ARTIS Ventures.
Bruce Bauer is the CEO of TAE Life Sciences, a medical technology company focused on commercializing medical innovations leveraging accelerator-based neutron beam technology for Boron Neutron Capture Therapy (BNCT). The company aims to provide treatment potential for various cancers, including head and neck, and glioblastoma multiforme. TAE Life Sciences has raised $40 million in venture capital. Bauer has over 20 years of experience leading investments in healthcare, security, imaging, enterprise software, and industrial businesses, and previously founded Newbury Ventures.
Full founder directory · Investor directory · Company funding database · Fundraising library